We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+8.39%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$7.35B
AUM Growth
-$124M
(-1.7%)
Cap. Flow
-$457M
Cap. Flow
% of AUM
-6.22%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
945
New
203
Increased
182
Reduced
140
Closed
326
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$135M |
| 2 |
Keysight
KEYS
|
+$120M |
| 3 |
Baxter International
BAX
|
+$102M |
| 4 |
RTX Corp
RTX
|
+$96.1M |
| 5 |
Revolution Medicines
RVMD
|
+$73.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$173M |
| 2 |
Teradyne
TER
|
+$107M |
| 3 |
Booking.com
BKNG
|
+$95.2M |
| 4 |
Electronic Arts
EA
|
+$85.2M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.2% |
| 2 | Technology | 26.7% |
| 3 | Industrials | 12.14% |
| 4 | Consumer Discretionary | 7.06% |
| 5 | Communication Services | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
301
DELISTED
Blueprint Medicines
BPMC
| $4.74M | 0.06% |
105,377
-135,317
| -56% | -$6.1M |
|
302
Illumina
ILMN
$29.3B
| $4.73M | 0.06% |
+20,894
| New | +$4.28M |
|
303
Krispy Kreme
DNUT
$557M
| $4.7M | 0.06% |
+302,472
| New | +$3.92M |
|
|
AEAE
304
DELISTED
AltEnergy Acquisition Corp
AEAE
| $4.67M | 0.06% |
450,000
| – | – |
|
305
Fox Class A
FOXA
$25.9B
| $4.65M | 0.06% |
136,635
-357,405
| -72% | -$12.1M |
|
306
Rockwell Automation
ROK
$49.2B
| $4.65M | 0.06% |
+15,851
| New | +$4.51M |
|
307
Acadia Healthcare
ACHC
$2.86B
| $4.64M | 0.06% |
64,236
-30,853
| -32% | -$2.4M |
|
308
Ardelyx
ARDX
$1.2B
| $4.62M | 0.06% |
964,999
-2,510,961
| -72% | -$8.47M |
|
309
Relay Therapeutics
RLAY
$4.3B
| $4.53M | 0.06% |
275,000
-56,663
| -17% | -$1.02M |
|
|
KMF
310
DELISTED
Kayne Anderson NextGen Energy & Infrastructure, Inc.
KMF
| $4.43M | 0.06% |
576,228
-45,703
| -7% | -$341K |
|
|
AHRN
311
DELISTED
Ahren Acquisition Corp
AHRN
| $4.42M | 0.06% |
425,000
| – | – |
|
312
Pacira BioSciences
PCRX
$1.02B
| $4.42M | 0.06% |
108,371
+17,724
| +20% | +$705K |
|
|
PRO
313
DELISTED
PROS Holdings
PRO
| $4.41M | 0.06% |
160,907
+6,110
| +4% | +$159K |
|
314
Eagle Materials
EXP
$6.48B
| $4.37M | 0.06% |
+29,746
| New | +$4.22M |
|
315
Portillo's
PTLO
$317M
| $4.35M | 0.06% |
+203,641
| New | +$4.28M |
|
316
VF Corp
VFC
$5.8B
| $4.26M | 0.06% |
+186,020
| New | +$4.89M |
|
|
VTYX
317
DELISTED
Ventyx Biosciences
VTYX
| $4.24M | 0.06% |
126,714
+6,701
| +6% | +$261K |
|
318
Qualys
QLYS
$6.29B
| $4.22M | 0.06% |
+32,468
| New | +$3.8M |
|
319
Calidi Biotherapeutics
CLDI
$2.16M
| $4.11M | 0.06% |
208
| – | – |
|
|
ARYE
320
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
| $4.09M | 0.06% |
400,000
| – | – |
|
321
Structure Therapeutics
GPCR
$3.74B
| $4.04M | 0.06% |
+170,000
| New | +$3.99M |
|
|
SUMO
322
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $4M | 0.05% |
+334,181
| New | +$3.66M |
|
|
SYNH
323
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4M | 0.05% |
+112,209
| New | +$4.07M |
|
|
KLRS
324
Kalaris Therapeutics
KLRS
$99.7M
| $3.94M | 0.05% |
43,478
-3,787
| -8% | -$482K |
|
325
Generac Holdings
GNRC
$12.5B
| $3.94M | 0.05% |
+36,442
| New | +$4.22M |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Woodline Partners held 945 positions worth $7.35B, down 1.7% from $7.47B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Woodline Partners withdrew a net $457M in Q1 2023, closing 326 positions and reducing 140 holdings. Its most notable exit was Electronic Arts, an estimated $85.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
Against the trend, Woodline Partners opened a new position in Amphenol worth $139M.
- Woodline Partners's largest Q1 2023 buy was Amphenol: 3,410,252 shares worth $139M.
- Woodline Partners added most to Baxter International in Q1 2023, an estimated $102M increase.
- Woodline Partners's biggest Q1 2023 reduction was TE Connectivity, cutting an estimated $173M.
- Woodline Partners fully exited Electronic Arts in Q1 2023, selling an estimated $85.2M.
- Woodline Partners's ten largest holdings make up 17% of its $7.35B portfolio in Q1 2023.
- Woodline Partners opened 203 new positions and closed 326 in Q1 2023.
- Woodline Partners's portfolio value fell 1.7% quarter-over-quarter to $7.35B.
Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.